Project Grant R01GM162041
- Federal Grant Award Summary The University of California, Davis received a $298,228 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded on June 6, 2025, with a completion date of December 5, 2026. The grant supports fundamental research into the spectroscopic characterization of enzymatic intermediates containing iron-sulfur clusters, which are critical biological structures found across all life...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of California, San Diego a $638,334 Project Grant on September 8, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to develop innovative computational methods for drug design. The project, extending through August 31, 2027, focuses on advancing understanding of protein-small molecule binding mechanisms by creating novel computational approaches for...
- Federal Grant Award Summary The University of California, Davis received a $435,769 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 1, 2025, with completion anticipated August 31, 2030. The award supports fundamental research into the physical biology of the cellular glycocalyx—the sugar- and protein-rich material covering all cells—with the objective of uncovering the physical...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $501,000 to The Regents of the University of California, San Francisco under the Biomedical Research and Research Training program (CFDA 93.859) on September 5, 2025, for a project titled "Bridging the Gap Between Prediction and Reality in Structural Biology." This five-year project, concluding May 31, 2030, focuses on developing computational tools and methodologies to advance...
- Federal Grant Award Summary The University of California, Davis received a $402,051 Project Grant award dated February 26, 2026, from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859). The award supports a multi-glycomic characterization research initiative extending through December 31, 2030, focused on developing integrated analytical platforms and methodologies to advance understanding of cell membrane glycosylation...
- Federal Project Grant Award Summary The University of California, Davis received a $432,417 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion targeted for January 31, 2031. This award supports investigator-initiated fundamental biomedical research examining the mechanisms by which extracellular matrix (ECM) mechanical properties regulate cellular...
- Federal Project Grant Award Summary The University of California, Davis received a $431,614 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025, through July 31, 2030. This fundamental research project investigates the biochemical and structural mechanisms regulating alpha/beta tubulin biogenesis and microtubule polymerization, with specific focus on how tubulin...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a $299,452 Project Grant to the University of California, Davis on May 20, 2025, under the Biomedical Research and Research Training program (CFDA 93.859). The research project, titled "Identification of the Core Organizational Principles Within Nuclear mRNAs," will be conducted through December 31, 2027, at UC Davis's Davis, California campus. This fundamental biomedical research...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant of $361,952 to the University of California, Berkeley, effective September 1, 2025 through June 30, 2030, under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research focused on developing experimental methods to systematically explore the mutational landscape of biomedically relevant proteins, specifically CRISPR-Cas genome...
- Federal Project Grant Award Summary The University of California, San Diego received a $327,019 Project Grant award dated July 25, 2025, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research through April 30, 2030, focusing on developing innovative biophysical and computational frameworks to understand how cells transform during embryogenesis and stem cell differentiation. The...
The University of California, Davis received a $341,970 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), with an award date of March 15, 2026 and completion date of February 28, 2030. The grant supports the development of polarizable Gaussian multipole force fields for biomolecular simulations, focusing on physics-based molecular modeling methods to advance computational capabilities in biochemical and biophysical research. The project deliverables include: (1) development of polarizable force field parameters for proteins, nucleic acids, and drug-like molecules, including parameterization of charges, permanent dipoles, van der Waals, and torsion potentials; (2) validation and refinement of force field parameters through rigorous testing against experimental and quantum mechanical data; (3) creation of a continuum solvent method for efficient binding free energy calculations; and (4) novel methodological advances for improved modeling of charge transfer and atomic quadrupoles. This research builds upon the investigator's prior work with AMBER polarizable force fields and aims to enhance molecular simulation platforms for biological structure, dynamics, and interactions while maintaining computational efficiency necessary for biologically relevant temporal and spatial scales. The work will have broad applications across biochemical, biophysical, and biotechnological domains, advancing fundamental molecular simulation capabilities that support drug discovery, protein engineering, and other biomolecular research applications.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $342.0k | 3/13/26 |